Results 101 to 110 of about 6,383 (147)

Rapid and robust immune response boosting with potent, next-generation adjuvant in viral vector-primed primates. [PDF]

J Virol
King HAD, Subra C, Tourtellott E, Swafford I, Basu S, Rossman M, Phillips L, Obarorakpor N, Ding S, Ferrari MG, Beck Z, Lewitus E, Bai H, Dong M, Slike BM, Kim D, Dussupt V, Mendez-Rivera L, Eisel N, Zhang L, Williams LD, Tomaras GD, Finzi A, Matyas GR, Krebs SJ, Rolland M, Rao M, Paquin-Proulx D, Bolton DL.   +28 more
europepmc   +1 more source

Drug Delivery Systems Repurposing Taxanes as Antitumor Immune Modulators. [PDF]

Biomater Res
Choi SH, Chi SH, Han CY, Cho KJ, Son S, Thomas SN, Kim J.   +6 more
europepmc   +1 more source

Multi-sensor observations and modeling of wave swash on a low-tide terrace beach. [PDF]

Sci Rep
Diaz H, Boucharel J, Marchesiello P, Almar R, Soufflet Y, Benshila R, Thuan DH, Viet NT, Almeida LP.   +8 more
europepmc   +1 more source

Development and non-clinical characterization of Procizumab (invobenitug): a humanized antibody neutralizing circulating DPP3. [PDF]

MAbs
Genest M, Van Lier D, Uba TI, Schroeter A, Picod A, Nordin H, Assad N, Marguerit G, Nguyen A, Bergmann A, Pickkers P, Mebazaa A, Santos K, Azibani F.   +13 more
europepmc   +1 more source

Vaccination of newborn monkeys with an influenza HA stem nanoparticle adjuvanted with R848 and AddaVax results in broadened HA recognition and increased antibody secreting cells to HA stem following H1N1 challenge. [PDF]

Front Immunol
Crofts KF, Holbrook BC, Hendrix CJ, DiPaolo AC, Page CL, Gillespie RA, Burkart HA, Kanekiyo M, Alexander-Miller MA.   +8 more
europepmc   +1 more source

Complementary efficacy of CD127-directed immunotherapy with lusvertikimab and ABL-targeting tyrosine kinase inhibitors in preclinical ABL-class-fusion-positive B-ALL. [PDF]

Hemasphere
Pinkle D, Cornils M, Dietterle A, Laqua A, Kurschies M, Heymann J, Funke E, Fanter P, Gupta DD, Reimer C, Mahachi DT, Gehlert CL, Winterberg D, Vossen-Gajcy M, Müller X, Balow G, Iben K, Barz M, Bastian L, Baldus C, Kowol M, Kikvadze S, Wurm AA, Logvinova E, Vokuhl C, Schmid JP, Jeremias I, Klausz K, Peipp M, Schrappe M, Baccelli I, Poirier N, Brüggemann M, Cario G, Schewe DM, Lenk L.   +35 more
europepmc   +1 more source

Fc-engineering for improved cancer immunotherapy. [PDF]

Biochem Soc Trans
Borgman E, Le Gall C, Ploegh H, Pishesha N.   +3 more
europepmc   +1 more source

Retargeted adenoviruses for local IgA and CD47 blocker production as a novel cancer therapy. [PDF]

EMBO Mol Med
Chernyavska M, Hartmann KP, Jansen JHM, Baumann N, Kolibius J, Brücher D, Kristoforus T, Peters RHW, Huijs L, Laarveld D, Weiss F, Burger R, Lustig M, Gimenez de Assis N, Schmid M, Leusen JHW, Valerius T, Plückthun A, Verdurmen WPR.   +18 more
europepmc   +1 more source

Assessment of entropy-derived 2D river velocity profiles from surface velocity radar measurements: case study of the Ganga and Bhagirathi rivers. [PDF]

Sci Rep
Kumar A, Jain MK.
europepmc   +1 more source

Tumor microenvironment remodeling by STING agonism sensitizes endothelial cells to cytotoxic anti-PD-L1/L2 antibody. [PDF]

J Exp Clin Cancer Res
Salameh A, Bolli E, Iezzi M, Gagliardi C, Conti L, Cossu C, Blezinger P, Lamolinara A, Lewis A, Curran MA, Cavallo F, Pericle F.   +11 more
europepmc   +1 more source